CClinicalTrials.gg
Status unknownNCT05539911Updated Oct 25, 2022

Fentanyl as an Adjuvant to Peribulbar Block in Buckle or Squint Surgeries

An Early Phase 1 interventional study of Fentanyl in Pain, sponsored by Research Institute of Ophthalmology, Egypt. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-10-25.

Sponsored by Research Institute of Ophthalmology, Egypt · Early Phase 1, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Oct 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Early Phase 1
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The use of fentanyl as an adjuvant to local anesthetic mixture in many regional blocks. It was effective when used in peribulbar block in cataract and vitreoretinal surgeries.

Our study will assess its efficacy in abolishing pain during muscle traction which is usually a complain for many patients a reason to use systemic opioid intra operatively or even general anesthesia

Read the detailed description

After the patient enters the OR room, an intravenous cannula will be introduced, pulse oximeter, ECG and NIBP monitors will be connected.

Nasal oxygen cannula connected; 10 ml of local anesthetic mixture is injected depending on the group the patient is allocated.

Increments of intravenous intravenous fentanyl and midazolam will be given if patient experienced unbearable pain.

All patient received peribulbar block by an experienced anesthesiologist, both patient and anesthesiologist were blinded to the drug mixture used.

Each patient received 10 ml of the anesthetic mixture according to his/ her group.

The patient was asked to fix his eyes looking straight forward toward the ceiling while lying in a supine position. A 10 ml syringe with a 25G needle was used for the local anesthetic injection. After negative aspiration, the first 5 ml were slowly injected at the junction of the lateral one third and medial two thirds of the inferior orbital margin with the bevel directed towards the equator of the eye ball parallel to the orbital floor and the other 5 ml were given between the caruncle and the medial canthus. Intermittent gentle massage was applied for 10 minutes. After satisfactory sensory and motor block, oxygen 3 L/min was delivered through a nasal cannula to the patient. Surgery was then allowed to proceed.

02

Conditions studied

  • Pain
03

In context

Lead sponsor

Research Institute of Ophthalmology, Egypt is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA 1, 2 \& 3
  • Age 18 to 70
  • Patients undergoing squint or buckle surgeries

Exclusion criteria

Exclusion Criteria:

  • Sensitivity to any drug used in this study
  • Refusal of the patient for peribulbar block
  • Redo squint surgeries or previous buckle insertion
  • High axial length if documented
  • mentally retarded patients and
  • failure of proper communication as in deafness,
  • coagulation abnormalities (INR>1.4),
  • infection at the injection site
05

Study design

Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    group f

    patient received 50 mic fentanyl as an adjuvant to the local anesthetic mixture applied during peribulbar block in the operative eye

    Drug: Fentanyl

  • Placebo comparator
    group C

    received the traditional mixture used

    Drug: Fentanyl

Interventions

  • DrugFentanyl

    50 mic fentanyl added as an adjuvant

06

What researchers measure

Primary outcomes

  1. pain during muscle traction

    numeric rating Scale for pain a scale from 0 to 10 where 0 is no pain and 10 is unbearable pain

    Time frame: Intraoperative period

Secondary outcomes

  1. surgeon satisfaction

    yes or no

    Time frame: intraoperative

07

Study locations

1 of 1 sites recruiting
  • Research Institute of Ophthalmology
    Giza, Egypt
    • Abeer Samir Salem, MD · Contact · 00201125666006
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05539911
Lead sponsor
Research Institute of Ophthalmology, Egypt
Responsible party
Sponsor
First posted
Sep 14, 2022
Start date
Sep 1, 2022
Primary completion
Nov 2022 (estimated)
Completion
Nov 2022 (estimated)
Last update
Oct 25, 2022

Study contacts

abeer S Salem, MD
Contact
abeersamirali@gmail.com
01125666006 ext. 002
Abeer S Salem, MD
principal investigator · Research Institute of Ophthalmology

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion